Wu, Liquan
Yuan, Qingfen
Wu, Lihao
Hua-Xiang Xia, Harry
Zhong, Muxiao
Liu, Tao
Ye, Xiaoyan
Luo, Danping
Xu, Jiating
Xie, Wenrui
He, Xingxiang
Cai, Jieyi
Funding for this research was provided by:
Science and Technology Program of Guangzhou, China (2023A04J1850)
Medical Scientific Research Foundation of Guangdong Province (A2020172)
Scientific Research Project of Guangdong Provincial Bureau of traditional Chinese Medicine (20221232)
Key-Area Research and Development Program of Guangdong Province (2022B1111070006)
Article History
Received: 8 February 2023
Accepted: 19 August 2023
First Online: 28 August 2023
Declarations
:
: The studies involving human participants were reviewed and approved by the Ethics Committee of the First Affiliated Hospital of Guangdong Pharmaceutical University. All methods were carried out in accordance with relevant guidelines and regulations. All enrolled patients signed the WMT treatment with informed consent.
: Not applicable.
: The authors declare that they have no competing interests.